Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/29/2025

Management of Chronic Constipation with Bloating and Fatigue

Initial Diagnostic Approach

  • The American Gastroenterological Association recommends checking for weight loss >10% of body weight, which suggests malabsorption, malignancy, or serious underlying disease requiring urgent workup 1
  • The American Gastroenterological Association suggests assessing for gastrointestinal bleeding (visible blood or melena), which requires urgent evaluation 1
  • The American Gastroenterological Association recommends screening for iron-deficiency anemia with tissue transglutaminase IgA and total IgA levels to exclude celiac disease 1
  • Obtaining inflammatory markers (CRP, albumin, platelets, fecal calprotectin) can help identify active inflammatory bowel disease, with normal results making it unlikely 2

First-Line Treatment Strategy

  • The American College of Gastroenterology recommends a trial of linaclotide 145 mcg daily on an empty stomach for 12 weeks, as this secretagogue directly addresses both constipation and bloating in patients presenting with this symptom complex 1
  • Implementing dietary changes, such as a low-FODMAP diet, can help alleviate symptoms of bloating and constipation, with lactose intolerance affecting 51% and fructose intolerance affecting 60% of patients with bloating 1

Pharmacological Management

  • Linaclotide 145 mcg once daily taken on an empty stomach at least 30 minutes before a meal produces rapid and sustained improvement in bowel habits, abdominal bloating, and quality of life, with 15.7% of patients meeting complete response criteria 1
  • The American College of Gastroenterology recommends considering lubiprostone as an alternative secretagogue if linaclotide is not tolerated, particularly when constipation is the dominant feature 1

Second-Line Considerations

  • The American Gastroenterological Association suggests considering rifaximin for patients with high-risk features, including prior GI surgery, pancreatic exocrine insufficiency, diabetes, or motility disorders 5, 1
  • Metoclopramide 10-20 mg every 6-8 hours is first-line for gastroparesis-related symptoms (nausea, vomiting, early satiety), but should be avoided in complete obstruction 1, 4

Addressing Fatigue

  • Assessing nutritional status and considering oral supplements or dietary adjustments can help alleviate fatigue in malnourished or at-risk patients 3
  • Involving a rheumatologist with expertise in fatigue management as part of multidisciplinary care can help address the fatigue component 3, 2

Critical Pitfalls to Avoid

  • The American College of Gastroenterology recommends avoiding the use of probiotics, as they are not recommended for abdominal bloating and distention 1
  • The American Gastroenterological Association suggests avoiding assuming gastroparesis based on symptoms alone, as bloating, nausea, and fullness do not correlate with gastric emptying delay on scintigraphy 1

When to Escalate Care

  • The American Gastroenterological Association recommends referring to a multidisciplinary team if symptoms persist despite 12 weeks of optimized medical therapy, or if nutritional status deteriorates (BMI falling below normal range) 3, 2

REFERENCES

1

Management of Gastrointestinal Symptoms [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Symptoms and Characteristics of Mild Small Intestinal Bacterial Overgrowth (SIBO) [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Initial Management of Ogilvie's Syndrome [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025